Compounds > 3-nitrobenzothiazolo(3,2-a)quinolinium
Page last updated: 2024-09-04

3-nitrobenzothiazolo(3,2-a)quinolinium and Acute Promyelocytic Leukemia

3-nitrobenzothiazolo(3,2-a)quinolinium has been researched along with Acute Promyelocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baez, A; Sepulveda, J1

Other Studies

1 other study(ies) available for 3-nitrobenzothiazolo(3,2-a)quinolinium and Acute Promyelocytic Leukemia

ArticleYear
Myeloid differentiation of HL-60 cells induced by anti-tumor drug 3-nitrobenzothiazolo[3,2-a]quinolinium.
    Leukemia research, 1992, Volume: 16, Issue:4

    Topics: Cell Cycle; Cell Differentiation; Cell Division; Drug Screening Assays, Antitumor; Granulocytes; Humans; Leukemia, Promyelocytic, Acute; Quinolinium Compounds; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1992